Pancreatic ductal adenocarcinoma ubiquitination profiling reveals specific prognostic and theranostic markers

[1]  A. Jemal,et al.  Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.

[2]  Dana R. Valley,et al.  Proteogenomic characterization of pancreatic ductal adenocarcinoma , 2021, Cell.

[3]  Lanjuan Li,et al.  Integrative proteomics reveals the role of E3 ubiquitin ligase SYVN1 in hepatocellular carcinoma metastasis , 2021, Cancer communications.

[4]  S. Boyault,et al.  Exploring the Complementarity of Pancreatic Ductal Adenocarcinoma Preclinical Models , 2021, Cancers.

[5]  L. Matrisian,et al.  Estimated Projection of US Cancer Incidence and Death to 2040 , 2021, JAMA network open.

[6]  A. Reyniès,et al.  A transcriptomic signature to predict adjuvant gemcitabine sensitivity in pancreatic adenocarcinoma. , 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  J. Iovanna,et al.  Basal‐like and classical cells coexist in pancreatic cancer revealed by single‐cell analysis on biopsy‐derived pancreatic cancer organoids from the classical subtype , 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  J. Iovanna,et al.  Evidencing a Pancreatic Ductal Adenocarcinoma Subpopulation Sensitive to the Proteasome Inhibitor Carfilzomib , 2020, Clinical Cancer Research.

[9]  J. Iovanna,et al.  Establishment of a pancreatic adenocarcinoma molecular gradient (PAMG) that predicts the clinical outcome of pancreatic cancer , 2020, bioRxiv.

[10]  Emalie J. Clement,et al.  The Proteomic Landscape of Pancreatic Ductal Adenocarcinoma Liver Metastases Identifies Molecular Subtypes and Associations with Clinical Response , 2019, Clinical Cancer Research.

[11]  Keith E. Volmar,et al.  Purity Independent Subtyping of Tumors (PurIST), A Clinically Robust, Single-sample Classifier for Tumor Subtyping in Pancreatic Cancer , 2019, Clinical Cancer Research.

[12]  A. Carrier,et al.  PML hyposumoylation is responsible for the resistance of pancreatic cancer , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  R. Moffitt,et al.  Keratin 17 identifies the most lethal molecular subtype of pancreatic cancer , 2019, Scientific Reports.

[14]  D. Franchimont,et al.  Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features. , 2018, Gastroenterology.

[15]  G. Ren,et al.  PSMD2 regulates breast cancer cell proliferation and cell cycle progression by modulating p21 and p27 proteasomal degradation. , 2018, Cancer letters.

[16]  Dorte B. Bekker-Jensen,et al.  UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites , 2018, Nature Structural & Molecular Biology.

[17]  R. Moffitt,et al.  Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial , 2017, Clinical Cancer Research.

[18]  J. Iovanna,et al.  Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts , 2017, Cell reports.

[19]  M. Hidalgo,et al.  Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[20]  I. Dikič.  Proteasomal and Autophagic Degradation Systems. , 2017, Annual review of biochemistry.

[21]  J. Qi,et al.  Gene expression profiling of patient‐derived pancreatic cancer xenografts predicts sensitivity to the BET bromodomain inhibitor JQ1: implications for individualized medicine efforts , 2017, EMBO molecular medicine.

[22]  K. Shi,et al.  Structures of Rpn1 T1:Rad23 and hRpn13:hPLIC2 Reveal Distinct Binding Mechanisms between Substrate Receptors and Shuttle Factors of the Proteasome. , 2016, Structure.

[23]  M. Rapé,et al.  The increasing complexity of the ubiquitin code , 2016, Nature Cell Biology.

[24]  Yi Qin,et al.  ALDOA functions as an oncogene in the highly metastatic pancreatic cancer. , 2016, Cancer letters.

[25]  R. Aebersold,et al.  On the Dependency of Cellular Protein Levels on mRNA Abundance , 2016, Cell.

[26]  R. Gibbs,et al.  Genomic analyses identify molecular subtypes of pancreatic cancer , 2016, Nature.

[27]  A. Rastogi,et al.  Endoscopic Ultrasound-Guided Fine-Needle Aspiration of Pancreatic Lesions: A Systematic Review of Technical and Procedural Variables , 2016, North American journal of medical sciences.

[28]  Jen Jen Yeh,et al.  Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma , 2015, Nature Genetics.

[29]  J. Iovanna,et al.  Transcriptomic analysis predicts survival and sensitivity to anticancer drugs of patients with a pancreatic adenocarcinoma. , 2015, The American journal of pathology.

[30]  R. Tomasini,et al.  Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma , 2015, Proceedings of the National Academy of Sciences.

[31]  Marco Y. Hein,et al.  Accurate Proteome-wide Label-free Quantification by Delayed Normalization and Maximal Peptide Ratio Extraction, Termed MaxLFQ * , 2014, Molecular & Cellular Proteomics.

[32]  Jean-Paul Borg,et al.  Identification of new mechanisms of cellular response to chemotherapy by tracking changes in post-translational modifications by ubiquitin and ubiquitin-like proteins. , 2014, Journal of proteome research.

[33]  Andrew R. Jones,et al.  ProteomeXchange provides globally co-ordinated proteomics data submission and dissemination , 2014, Nature Biotechnology.

[34]  Henning Hermjakob,et al.  The Reactome pathway knowledgebase , 2013, Nucleic Acids Res..

[35]  S. Carr,et al.  Large-scale identification of ubiquitination sites by mass spectrometry , 2013, Nature Protocols.

[36]  Wei Shi,et al.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..

[37]  Yanji Xu,et al.  Synaptic protein ubiquitination in rat brain revealed by antibody-based ubiquitome analysis. , 2012, Journal of proteome research.

[38]  Guangchuang Yu,et al.  clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.

[39]  R. Christopherson,et al.  Biomarkers of breast cancer apoptosis induced by chemotherapy and TRAIL. , 2012, Journal of proteome research.

[40]  P. Spellman,et al.  Subtypes of Pancreatic Ductal Adenocarcinoma and Their Differing Responses to Therapy , 2011, Nature Medicine.

[41]  V. Kirkin,et al.  Ubiquitin networks in cancer. , 2011, Current opinion in genetics & development.

[42]  P. Soubeyran,et al.  Protein Ubiquitylation in Pancreatic Cancer , 2010, TheScientificWorldJournal.

[43]  M. Mann,et al.  MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification , 2008, Nature Biotechnology.

[44]  I. Um,et al.  Relationship between differentially expressed mRNA and mRNA-protein correlations in a xenograft model system , 2015, Scientific Reports.